Cargando…
Additional germline findings from a tumor profiling program
BACKGROUND: Matched tumor-normal sequencing, applied in precision cancer medicine, can identify unidentified germline Medically Actionable Variants (gMAVS) in cancer predisposition genes. We report patient preferences for the return of additional germline results, and describe various gMAV scenarios...
Autores principales: | Stjepanovic, Neda, Stockley, Tracy L., Bedard, Philippe L., McCuaig, Jeanna M., Aronson, Melyssa, Holter, Spring, Semotiuk, Kara, Leighl, Natasha B., Jang, Raymond, Krzyzanowska, Monika K., Oza, Amit M., Gupta, Abha, Elser, Christine, Ahmed, Lailah, Wang, Lisa, Kamel-Reid, Suzanne, Siu, Lillian L., Kim, Raymond H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085686/ https://www.ncbi.nlm.nih.gov/pubmed/30092803 http://dx.doi.org/10.1186/s12920-018-0383-5 |
Ejemplares similares
-
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
por: Care, Melanie, et al.
Publicado: (2020) -
Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome
por: McGarragle, Kaitlin M., et al.
Publicado: (2019) -
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
por: McCuaig, Jeanna M., et al.
Publicado: (2022) -
Clinicopathologic and genetic features of young patients with colorectal cancer
por: Aronson, Melyssa, et al.
Publicado: (2010) -
Incidental findings from cancer next generation sequencing panels
por: Maani, Nika, et al.
Publicado: (2021)